Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer
Clinical trial NCT02581943 · COMPLETED
Trial details
- NCT number
- NCT02581943
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-17
- Primary completion
- 2022-11-19
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.